MY155011A - Hydroxy tetrahydro-naphthalenylurea derivatives - Google Patents
Hydroxy tetrahydro-naphthalenylurea derivativesInfo
- Publication number
- MY155011A MY155011A MYPI20031696A MYPI20031696A MY155011A MY 155011 A MY155011 A MY 155011A MY PI20031696 A MYPI20031696 A MY PI20031696A MY PI20031696 A MYPI20031696 A MY PI20031696A MY 155011 A MY155011 A MY 155011A
- Authority
- MY
- Malaysia
- Prior art keywords
- pain
- treatment
- hydroxy tetrahydro
- tetrahydro
- activity
- Prior art date
Links
- GYUVMUDBAKAYON-UHFFFAOYSA-N 1-hydroxy-1-(1,2,3,4-tetrahydronaphthalen-1-yl)urea Chemical class C1=CC=C2C(N(O)C(=O)N)CCCC2=C1 GYUVMUDBAKAYON-UHFFFAOYSA-N 0.000 title 1
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 208000028389 Nerve injury Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- 208000004550 Postoperative Pain Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000008764 nerve damage Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY155011A true MY155011A (en) | 2015-08-28 |
Family
ID=9936269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20031696A MY155011A (en) | 2002-05-08 | 2003-05-06 | Hydroxy tetrahydro-naphthalenylurea derivatives |
Country Status (13)
| Country | Link |
|---|---|
| KR (1) | KR101000688B1 (fr) |
| AR (1) | AR039983A1 (fr) |
| CU (1) | CU23422B7 (fr) |
| DO (1) | DOP2003000642A (fr) |
| EC (1) | ECSP045413A (fr) |
| GB (2) | GB0210512D0 (fr) |
| GT (1) | GT200300102A (fr) |
| MA (1) | MA30728B1 (fr) |
| MY (1) | MY155011A (fr) |
| PE (1) | PE20040363A1 (fr) |
| PT (1) | PT1506167E (fr) |
| UA (1) | UA77301C2 (fr) |
| ZA (1) | ZA200408993B (fr) |
-
2002
- 2002-05-08 GB GBGB0210512.0A patent/GB0210512D0/en not_active Ceased
- 2002-11-21 GB GBGB0227262.3A patent/GB0227262D0/en not_active Ceased
-
2003
- 2003-04-28 UA UA20041210079A patent/UA77301C2/uk unknown
- 2003-04-28 PT PT03722554T patent/PT1506167E/pt unknown
- 2003-04-28 KR KR1020047017969A patent/KR101000688B1/ko not_active Expired - Fee Related
- 2003-05-05 GT GT200300102A patent/GT200300102A/es unknown
- 2003-05-06 MY MYPI20031696A patent/MY155011A/en unknown
- 2003-05-07 DO DO2003000642A patent/DOP2003000642A/es unknown
- 2003-05-07 PE PE2003000445A patent/PE20040363A1/es not_active Application Discontinuation
- 2003-05-08 AR ARP030101614A patent/AR039983A1/es active IP Right Grant
-
2004
- 2004-11-04 CU CU20040254A patent/CU23422B7/es unknown
- 2004-11-05 MA MA27935A patent/MA30728B1/fr unknown
- 2004-11-05 ZA ZA2004/08993A patent/ZA200408993B/en unknown
- 2004-11-08 EC EC2004005413A patent/ECSP045413A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1506167E (pt) | 2007-12-10 |
| KR101000688B1 (ko) | 2010-12-10 |
| GB0227262D0 (en) | 2002-12-31 |
| KR20040108784A (ko) | 2004-12-24 |
| CU23422B7 (es) | 2009-09-08 |
| MA30728B1 (fr) | 2009-10-01 |
| ECSP045413A (es) | 2005-01-03 |
| DOP2003000642A (es) | 2003-11-15 |
| PE20040363A1 (es) | 2004-07-03 |
| GT200300102A (es) | 2004-03-17 |
| GB0210512D0 (en) | 2002-06-19 |
| UA77301C2 (en) | 2006-11-15 |
| AR039983A1 (es) | 2005-03-09 |
| ZA200408993B (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003294748A1 (en) | Tetrahydro-naphthalene derivatives | |
| WO2003014064A8 (fr) | Derives amines | |
| IL191824A0 (en) | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling | |
| WO2005112970A3 (fr) | Utilisation de gelsoline pour le traitement d'infections | |
| IL165004A0 (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| EP1893216A4 (fr) | Methodes et preparations pour le traitement de troubles oculaires | |
| PL1881823T3 (pl) | Kompozycje i sposoby leczenia chorób oczu | |
| ZA200607433B (en) | Methods and compositions for the treatment of gastroin-testinal disorders | |
| IL184371A0 (en) | Methods of treating skin disorders using an il-31ra antagonist | |
| EP1879578A4 (fr) | Methodes et compositions destinees au traitement de l'incontinence urinaire | |
| ZA200610661B (en) | Compositions and methods for treating neurological disorders | |
| IL189009A0 (en) | Methods and compositions for the treatment of neuropathies and related disorders | |
| WO2006074265A3 (fr) | Therapie combinee et compositions pharmaceutiques utilisees dans le traitement des troubles inflammatoires | |
| WO2005044200A3 (fr) | Procedes et compositions pour traiter des pathologies associees a la mcp-1 | |
| AU2003288200A1 (en) | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists | |
| WO2007053495A3 (fr) | Composes utiles en tant qu’antagonistes de ccr2 | |
| EP2248524A3 (fr) | Agents preventifs/remedes pour l'incontinence de stress et procede de selecetion de ceux-ci | |
| UA96926C2 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
| WO2006081516A3 (fr) | Utilisation de baff pour traiter des pathologies induites par th2 | |
| WO2006079068A3 (fr) | Compositions et methodes permettant d'etudier et de traiter des maladies et des troubles inflammatoires | |
| WO2007053499A3 (fr) | Composés pouvant être employés en tant qu'antagonistes de ccr2 | |
| IL181713A0 (en) | Use of il-17f for the treatment and/or prevention of neurological diseases | |
| TWI369984B (en) | Pharmaceutical compositions for treatment of overactive bladder associated with neurological disorders | |
| WO2004028440A3 (fr) | Utilisation d'antagonistes du recepteur vanilloide pour le traitement de troubles urologiques | |
| TN2010000579A1 (en) | Piperidinyl derivative as a modulator o chemokine receptor activity |